Dow Up 0.02% Nasdaq Down 0.17%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE
113.27 Down 0.45(0.40%) 10:12AM EDT - Nasdaq Real Time Price
Prev Close:113.72
Open:113.60
Bid:112.85 x 200
Ask:112.99 x 200
1y Target Est:52.38
Beta:1.14
Next Earnings Date:N/A
Day's Range:112.33 - 113.76
52wk Range:95.28 - 153.10
Volume:297,348
Avg Vol (3m):3,295,040
Market Cap:37.99B
P/E (ttm):N/A
EPS (ttm):-2.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VRXDown 0.40%37.99B
TEVAUp 0.06%45.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.07
Ex-Dividend Date:10-Nov-10

Analysts

Annual EPS Est (Dec-10) :N/A
Quarterly EPS Est (Sep-10) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback